Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TMA Precision Health
AddedFeb 17, 2024
UpdatedJun 18, 2026
TMA Precision Health

TMA Precision Health

Angel

TMA Precision Health: Enhancing lives with genome sequencing for rare disease treatment.

HQ
Boston, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

TMA Precision Health, founded with a mission to improve the lives of rare disease patients, focuses on ending the diagnostic odyssey for these individuals. The company offers genome sequencing services and a research platform that provides comprehensive information about diagnosed diseases, including related genes, repurposed drugs, existing care options, and active clinical trials. Their vision is to ensure that rare disease patients worldwide receive the medical care they need to lead happy and healthy lives.

Notable affiliated individuals and investors include experts in genomics and healthcare innovation, although specific names are not provided. Key achievements of TMA Precision Health include the development of their advanced research platform, which significantly accelerates the diagnostic process and treatment options for rare diseases. The overall impact of TMA Precision Health lies in its potential to transform the healthcare landscape for rare disease patients by providing timely and accurate diagnostic information, thereby improving patient outcomes and quality of life.

TMA Precision Health - Similar Companies

Toma Biosciences logo

Toma Biosciences

tomabio.com

Variantyx logo

Variantyx

variantyx.com

Precision Theranostics logo

Precision Theranostics

Genome Insight logo

Genome Insight

Probably Genetic logo

Probably Genetic

Genome Medical logo

Genome Medical

genomemedical.com

Rare Disease Data Trust logo

Rare Disease Data Trust

finding-rare.com

ThinkGenetic logo

ThinkGenetic

thinkgenetic.com

Sequegenics logo

Sequegenics

sequegenics.com

Genetron Health logo

Genetron Health

genetronhealth.com

Geneial logo

Geneial

geneial.com

Unite Genomics logo

Unite Genomics

Ariel Precision Medicine logo

Ariel Precision Medicine

arielmedicine.com

Inform Genomics logo

Inform Genomics

informgenomics.com

Base5 Genomics logo

Base5 Genomics

b5genomics.com

TMA Precision Health - Quick Facts

Who are TMA Precision Health's competitors?

Companies similar to TMA Precision Health include Toma Biosciences, Variantyx, Precision Theranostics and Genome Insight.

When was TMA Precision Health founded?

TMA Precision Health was founded in 2019.

Where is TMA Precision Health's headquarters located?

TMA Precision Health's headquarters is located in Boston, MA, US.

When was TMA Precision Health's last funding round?

TMA Precision Health's most recent funding round was for $20k (USD) in August 2022.

How much has TMA Precision Health raised to-date?

As of Aug 5, 2022, TMA Precision Health has raised a total of $20k (USD).

How many employees does TMA Precision Health have?

TMA Precision Health has 3 employees as of Feb 4, 2024.

TMA Precision Health - Classification

Technology
  • Analytics
  • GenAI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Genome Sequencing
  • Research Platform
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research